Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does EMTRICITABINE Cause Malaise? 10 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Malaise have been filed in association with EMTRICITABINE (Truvada). This represents 0.3% of all adverse event reports for EMTRICITABINE.

10
Reports of Malaise with EMTRICITABINE
0.3%
of all EMTRICITABINE reports
0
Deaths
4
Hospitalizations

How Dangerous Is Malaise From EMTRICITABINE?

Of the 10 reports, 4 (40.0%) required hospitalization, and 2 (20.0%) were considered life-threatening.

Is Malaise Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for EMTRICITABINE. However, 10 reports have been filed with the FAERS database.

What Other Side Effects Does EMTRICITABINE Cause?

Foetal exposure during pregnancy (609) Drug resistance (370) Virologic failure (331) Immune reconstitution inflammatory syndrome (262) Exposure during pregnancy (212) Drug ineffective (196) Pathogen resistance (166) Viral mutation identified (161) Maternal exposure during pregnancy (160) Death (154)

What Other Drugs Cause Malaise?

ADALIMUMAB (15,965) ETANERCEPT (13,600) METHOTREXATE (9,970) TOFACITINIB (9,040) SECUKINUMAB (8,570) INFLIXIMAB (7,477) RITUXIMAB (6,587) PREGABALIN (6,320) PREDNISONE (6,319) ABATACEPT (6,251)

Which EMTRICITABINE Alternatives Have Lower Malaise Risk?

EMTRICITABINE vs EMTRICITABINE\RILPIVIRINE\TENOFOVIR ALAFENAMIDE EMTRICITABINE vs EMTRICITABINE\RILPIVIRINE\TENOFOVIR DISOPROXIL EMTRICITABINE vs EMTRICITABINE\TENOFOVIR EMTRICITABINE vs EMTRICITABINE\TENOFOVIR ALAFENAMIDE EMTRICITABINE vs EMTRICITABINE/TENOFOVIR DISOPROXIL

Related Pages

EMTRICITABINE Full Profile All Malaise Reports All Drugs Causing Malaise EMTRICITABINE Demographics